
Loading, please wait...

Loading, please wait...

Modern catheter technology has rapidly advanced the multidisciplinary management of complex cranial, cervical, and facial conditions. Today, head and neck embolization serves as a vital intervention for treating vascular tumors, arresting catastrophic hemorrhage, and delivering targeted chemotherapy. Consequently, interventional radiologists collaborate with head and neck surgeons to establish precise treatment pathways. However, complex skull base vascular networks require meticulous technique to avoid unintended ischemic harm. Moreover, rigorous pre-procedural angiographic mapping ensures high therapeutic efficacy across varied emergency and elective presentations.
Superselective intra-arterial chemoradiotherapy, known as RADPLAT, delivers high concentrations of antineoplastic agents directly into tumor-feeding vessels. Clinicians administer cisplatin through microcatheters navigated into specific branches of the external carotid artery. Concurrently, medical teams infuse intravenous sodium thiosulfate to neutralize cisplatin toxicity and preserve renal function. Therefore, this targeted intra-arterial approach achieves potent local tumor control without inducing intolerable systemic side effects. Moreover, oncology teams combine RADPLAT with definitive radiotherapy to enhance organ preservation in advanced malignancies. For instance, patients with advanced maxillary sinus carcinoma achieve functional organ salvage through this multimodal protocol. Operators also assess patient renal markers and vascular tortuosity to prevent procedural delays. Furthermore, real-time hemodynamic monitoring ensures drug delivery remains strictly localized to the target neoplasm. Diagnostic angiography confirms tumor blush and defines microvascular architecture before drug administration. In addition, high-resolution cone-beam computed tomography during catheterization verifies complete target perfusion and confirms the absence of non-target distribution. Thus, RADPLAT remains an indispensable treatment pathway for unresectable regional disease. Consequently, patients experience notable tumor regression alongside reduced functional impairment of vital swallowing structures. Similarly, post-infusion imaging confirms complete local vascular clearance without residual untoward tissue ischemia.
Preoperative devascularization facilitates the safe resection of hypervascular head and neck neoplasms. Specifically, pathologies such as juvenile nasopharyngeal angiofibromas, paragangliomas, and skull base meningiomas benefit profoundly from targeted endovascular occlusion. Interventionists introduce calibrated embolic particles or liquid embolic materials to occlude distal tumor microvessels. For example, operators routinely utilize polyvinyl alcohol particles or tris-acryl gelatin microspheres sized between 150 and 500 microns. Furthermore, liquid embolic agents, such as ethylene vinyl alcohol copolymer, provide permanent and deeper penetration into extensive nidus networks. As a result, surgeons observe dramatically reduced intraoperative blood loss and shorter operative durations. In addition, reduced vascular engorgement enhances anatomical visualization, which safeguards adjacent cranial nerves during dissection. However, operators must execute particulate embolization strictly distal to critical physiological collaterals. Premature proximal vessel occlusion triggers collateral recruitment from deep cervical channels, which undermines surgical devascularization. Therefore, clinicians schedule surgical extirpation within twenty-four to seventy-two hours following endovascular embolization to avoid post-procedural recanalization. Consequently, comprehensive pre-procedural planning directly lowers allogeneic transfusion requirements for surgical patients. Ultimately, this structured interventional protocol ensures superior surgical field clearance and promotes rapid recovery.
Endovascular intervention provides immediate, life-saving control during catastrophic cervicofacial hemorrhage. For instance, intractable posterior epistaxis that fails anterior and posterior nasal packing often responds rapidly to superselective transarterial embolization. Operators catheterize distal branches of the internal maxillary artery or sphenopalatine artery using microcoils or small particles. Furthermore, emergency teams increasingly encounter carotid blowout syndrome in patients treated with radical surgery and high-dose radiotherapy. Radiation-induced arterial necrosis, wound infection, and tumor recurrence weaken the arterial wall, creating life-threatening pseudoaneurysms or frank arterial ruptures. Consequently, patients present with threatened, impending, or acute exsanguinating hemorrhage. Interventional radiologists immediately perform diagnostic angiography to assess vascular integrity and collateral intracranial perfusion. When collateral flow across the circle of Willis remains robust, operators achieve definitive hemostasis through parent vessel sacrifice using dense detachable coil packing. Conversely, if collateral cerebral blood flow is inadequate, clinicians deploy self-expanding covered stents to maintain carotid artery patency while sealing the mural rupture. Although covered stents risk delayed infection in contaminated surgical beds, they offer rapid stabilization. Thus, emergency endovascular therapy remains the primary rescue modality for severe cervicofacial bleeding. Furthermore, serial post-intervention cross-sectional imaging monitors vascular stability and detects early signs of delayed rebleeding.
Safe execution of cervical endovascular therapy requires thorough mastery of skull base vascular anatomy. Dangerous anastomoses connect external carotid branches to the internal carotid and vertebral arterial systems. For example, the middle meningeal artery frequently forms direct communications with the ophthalmic artery through recurrent meningeal branches. Similarly, the neuromeningeal branch of the ascending pharyngeal artery connects directly to the hypoglossal canal and vertebral circulation. Inadvertent particulate reflux into these anastomotic conduits can trigger catastrophic complications, including irreversible blindness and ischemic stroke. Therefore, interventional radiologists must perform meticulous selective digital subtraction angiography prior to injecting any embolic substance. Clinicians routinely use high-resolution microcatheters positioned deeply within target branches beyond anastomotic bifurcations. Moreover, interventionists utilize continuous real-time fluoroscopic roadmapping to detect early retrograde reflux during material delivery. If dangerous anastomotic connections appear prominent, operators adjust the microcatheter tip or select microcoils rather than freely circulating liquid agents. Additionally, pharmacological provocative testing with intra-arterial amobarbital helps verify neurological safety in challenging anatomical variants. Consequently, rigorous anatomical surveillance eliminates preventable neurological deficits during complex cranial and facial embolization procedures. Furthermore, continuous visual monitoring during particle delivery prevents involuntary reflux into non-target intracranial branches.
Recent technological innovations have elevated the precision and clinical safety of head and neck interventions. Modern biplane angiography suites incorporate advanced cone-beam computed tomography, providing cross-sectional soft-tissue resolution within the intervention room. Furthermore, clinicians employ dual-phase cone-beam protocols to verify parenchymal tumor margins and evaluate microcatheter tip stability. In addition, three-dimensional roadmapping software overlays pre-procedural cross-sectional imaging directly onto live fluoroscopy. As a result, interventionists navigate complex, tortuous skull base vessels with greater mechanical speed and reduced radiation exposure. Concurrently, researchers are rapidly integrating artificial intelligence algorithms into endovascular workflows. Machine learning platforms automatically identify subtle dangerous anastomoses on pre-procedural computed tomography angiography. Moreover, deep learning algorithms analyze dynamic perfusion metrics, which assists operators in predicting tissue necrosis risk during tumor embolization. Artificial intelligence tools also provide predictive modeling for carotid blowout risk in previously irradiated patients. Therefore, clinical teams identify vulnerable vascular segments long before catastrophic mural rupture manifests. Consequently, interventionists achieve superior precision while minimizing iodinated contrast doses and procedural times. Ultimately, integrating computerized analytics empowers multidisciplinary teams to formulate safer, individualized treatment algorithms for complex lesions. In addition, automated volumetric software reliably quantifies post-embolization devascularization to assist operating surgeons.
Clinicians determine the optimal strategy by evaluating the patient's neurological collateral capacity and local infection status. Operators perform temporary balloon test occlusion with angiographic evaluation to assess circle of Willis cross-filling. When collateral intracranial perfusion remains robust, permanent parent artery occlusion provides superior durability and prevents recurrent hemorrhage. Conversely, if cerebral collateralization is inadequate, interventionists deploy covered stents to maintain luminal patency, although local microbial contamination increases late thrombosis risks.
Interventionists must identify anastomoses between the maxillary artery and the ophthalmic or internal carotid systems. Specifically, the anterior deep temporal and middle meningeal arteries can connect directly to the ophthalmic artery, presenting severe blindness risks. Furthermore, the sphenopalatine and vidian branches frequently communicate with the petrous internal carotid artery. Operators inject dilute contrast under continuous high-resolution fluoroscopy to detect anomalous retrograde flow, ensuring embolic particles never migrate into intracranial or orbital circulations.
Superselective intra-arterial chemoradiotherapy delivers concentrated chemotherapy directly into the tumor feeding bed through a microcatheter. This localized delivery achieves exceptionally high intratumoral drug concentrations while keeping total systemic doses relatively low. Additionally, clinical teams administer intravenous neutralizing antidotes, such as sodium thiosulfate, concurrently during the intra-arterial infusion. This systemic neutralization rapidly binds circulating free platinum molecules, successfully protecting kidney tubules and bone marrow from severe systemic injury without diminishing targeted tumoricidal efficacy.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Interventional radiology of the head and neck encompasses intra-arterial chemoradiotherapy (RADPLAT), tumor embolization, and urgent hemostasis for carotid blowout syndrome and epistaxis while navigating complex skull base anastomoses.
Today

Drug safety management evolves across a therapeutic product's entire lifecycle. This review examines regulatory standards, active surveillance, AI-supported pharmacovigilance, and pragmatic strategies to mitigate clinical risk from bench to bedside.
Today

A landmark study reveals that congenital DLK1 deficiency in women with a history of central precocious puberty causes visceral adiposity, mitochondrial dysfunction, oxidative stress, and neutrophil activation, highlighting the critical need for lifelong cardiometabolic surveillance.
Today

A cross-sectional study evaluates the critical intersection between acute surgical pain, kinesiophobia, and fall risks during initial mobilization after cardiac surgery, emphasizing targeted nursing strategies.
Today

A recent cross-sectional analysis reveals that over a quarter of randomized controlled trials for non-specific low back pain face discontinuation or unknown status, while more than 36% of completed trials remain unpublished, exposing notable reporting gaps in spine and musculoskeletal clinical research.
Today

Explore revascularisation strategies in dialysis-dependent chronic limb-threatening ischaemia. This review examines surgical bypass vs endovascular therapy, BEST-CLI trial findings, procedural morbidity, conduit availability, and multidisciplinary decision-making for optimal limb salvage.
Today